| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Computers and Technology > Computers and Technology > Setting Up eGovernment IT Systems - Over Coming Excuses - Weakness and Illness in Humans |
|
Top Adding - Setting Up eGovernment IT Systems - Over Coming Excuses - Weakness and Illness in Humans
We all know the importance that IT systems will play in the future of running our government. But what about the problem in implementation that they huma According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ns setting it up have? Is such weakness, illness and excuse making too high of a barrier to over come? It appears so. Some say that we must accept the tr ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in uth that humans are weak and problematic and the government does nothing very well. I say the government does do some things very well; well like wastefu lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. lly spending our money for instance. Those setting up an IT System must be at the Top of their Game all the time. Now then many believe we must cut thes here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e bureaucrats and professionals some slack, they are only human? Interesting because we must not integrate poor work ethic, excuses or lethargic tendenci d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s into our Artificially Intelligent Government IT Systems. Some say a little weakness is okay and it is okay just to get by. Okay then, let's take your ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc premise and apply this to the "eGovernment" inadequate implementation sited in GAO reviews of e-Government. It seems that humans in Government have procl easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi aimed that they want the new "e-Government" systems, but give it lip-service, especially when it comes to the transparency and accountability part. In ot nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically her words they say one thing to the public, do another. Lack of integrity is prevalent amongst humans; let's call this a Weakness. Next let us consider and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the lack of buy-in from the bureaucrats, even though they were involved in the process and committed to the mission. But they ran into barriers, problems ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi and challenges and well, they were able to use those as; Excuses? Indeed we see a problem in modern human societies which is spreading amongst the masse ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s, that as long as the means are correct then the ends are irrelevant. Yet in the GAO report it points out clearly that the results are not satisfactory. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod So, if I may be so bold, let us call the spreading of lackluster performance, piss poor results and lack of hard work ethic a pandemic. Thus an illness. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin The mission is paramount. So, if the eGovernment initiatives are failing, even though they are the future, then if we allow excuses, weakness and illne tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ss in the process the future will be filled with unfulfilled promises, leading to further decay of the civilization or society. The Foundation of the fut t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel re period must be built with strength at the head of the fountain or those holding up the system in the future will shrug and drop the ball. The system ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust must work no matter what, and so if one is intimately involved in the designing of IT then they need to get with the program and offer no excuses. Failur y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e is not an option. You must always be at the top of your game if you want to win and achieve victory. That is to say compete the project successfully a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nd make it work, in my humble opinion. The Ends matter as much, as the means. certainly hope this article is of interest and that is has propelled though elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip t. The goal is simple; to help you in your quest to be the best in 2007. I thank you for reading my many articles on diverse subjects, which interest you tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Forex Trading is NOT Just for the Pros Self-Publishing - Debacle or Solution
|